Z. Rakhmanova

发表

The influence of various doses of busulfan in conditioning regimes on outcome of allogeneic hematopoietic stem cell transplantation in children with acute myeloid leukemia

B. Afanasyev, L. Zubarovskaya, I. Barkhatov, 2020, Pediatric Hematology/Oncology and Immunopathology.

Efficiency of second allogeneic HSCT in the children with acute leukemias with relapses after first transplantation

B. Afanasyev, E. Babenko, L. Zubarovskaya, 2019, Cellular Therapy and Transplantation.

Ten-year experience of allogeneic haploidentical hematopoietic stem cell transplantation with non-manipulated grafts in children and adolescents with high-risk acute leukemia

B. Afanasyev, S. Bondarenko, L. Zubarovskaya, 2018, Cellular Therapy and Transplantation.

Quantitative study of BAALC- and WT1-expressing cell precursors in the patients with different cytogenetic and molecular AML variants treated with Gemtuzumab ozogamicin and hematopoietic stem cell transplantation

N. Mamaev, S. Bondarenko, L. Zubarovskaya, 2021 .

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease

I. Moiseev, A. Chukhlovin, S. Bondarenko, 2021, Pharmaceuticals.

Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation

A. G. Volkova, A. Frolova, E. Dobrovolskaya, 2022, The Scientific Notes of the Pavlov University.

Immunotherapy of high-risk infant acute lymphoblastic leukemia using blinatumomab and infusion of donor lymphocytes

I. Barkhatov, A. Frolova, A. Kulagin, 2022, Pediatric Hematology/Oncology and Immunopathology.

The results of allogeneic hematopoietic stem cell transplantation from a matched unrelated and haploidentical donors in children with high-risk infant leukemia in first and second remissions

B. Afanasyev, L. Zubarovskaya, I. Barkhatov, 2020, Pediatric Hematology/Oncology and Immunopathology.

An analysis of the efficacy of graft-versus-host disease prophylaxis with post-transplant cyclophosphamide in children with acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation from HLA-matched and partially-matched unrelated donors

I. Moiseev, A. Kulagin, L. Tsvetkova, 2023, Pediatric Hematology/Oncology and Immunopathology.

The prognostic value of HLA loss of heterozygosity after allogeneic hematopoietic stem cell transplantation in children with relapsed acute leukemia

I. Barkhatov, A. Frolova, A. Kulagin, 2023, Pediatric Hematology/Oncology and Immunopathology.

Post-transplant сyclophosphamide after matched donor hematopoietic stem cell transplantation in children with acute leukemia.

O. Goloshchapov, I. Moiseev, L. Zubarovskaya, 2023, Clinical Transplantation.